Gestational weight gain in persons with HIV in the United States

Keyphrases

• Antiretroviral Therapy 100%
• Antiretroviral Therapy Initiation 6%
• During Pregnancy 6%
• Excessive Gestational Weight Gain 20%
• Generalized Estimating Equations 6%
• Gestational Weight Gain 100%
• Inadequate Gestational Weight Gain 6%
• Integrase Inhibitors 6%
• Integrase Strand Transfer Inhibitor (INSTI) 20%
• Linear Regression Model 6%
• Maternal-child Health 6%
• Modified Poisson Regression 6%
• National Academy of Medicine 6%
• Non-associated 6%
• Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) 6%
• Nucleoside Reverse Transcriptase Inhibitors 6%
• Obese Men 6%
• People Living with HIV (PLHIV) 100%
• Poisson Regression 6%
• Pre-pregnancy BMI 13%
• Pregnant Women 6%
• Protease Inhibitors 13%
• Second Trimester 13%
• Surveillance Monitoring 6%
• Third Trimester 13%
• Toxicity Study 6%
• Treatment Class 20%
• Treatment Toxicity 6%
• Type Classes 6%
• United States 100%

Pharmacology, Toxicology and Pharmaceutical Science

• Cohort Study 20%
• HIV 100%
• Integrase Inhibitor 20%
• Nonnucleoside Reverse Transcriptase Inhibitor 20%
• Obesity 60%
• Proteinase Inhibitor 40%
• RNA Directed DNA Polymerase Inhibitor 20%